SER
Serina Therapeutics Inc
2.30$
+2.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 54.7% | 48.8% | 60.2% | 57.8% | 2,372.2% | 109.6% | 29.0% | 2.9% | 346.4% | 65.4% | |
| 45.3% | 51.2% | 39.8% | 42.2% | -2,272.2% | -9.6% | 100.0% | 97.1% | -246.4% | 34.6% | |
| 472.5% | 375.1% | 383.5% | 309.4% | 6,633.3% | 109.6% | 314.6% | 75.7% | 13,357.1% | 10,119.2% | |
| – | – | – | – | – | 37.5% | 257.8% | 123.5% | 17,185.7% | 8,459.2% | |
| 810.0% | 650.7% | 788.0% | 769.0% | 17,000.0% | 37.5% | 554.1% | 196.4% | 30,196.4% | 18,478.5% | |
| -764.6% | -599.5% | -748.2% | -726.8% | -19,272.2% | -47.1% | -454.1% | -99.2% | -30,442.9% | -18,478.5% | |
| 1.5% | 0.9% | – | – | 748.1% | 0.1% | 3.2% | 17.7% | 939.3% | 163.8% | |
| -1,041.7% | -472.7% | -553.8% | -708.1% | -19,257.4% | -36.5% | -536.4% | 167.1% | -20,012.5% | -14,766.9% | |
| -111.8% | -4.1% | -16.4% | 8.6% | 863.0% | 0.1% | -50.0% | -0.3% | – | 13.8% | |
| -929.9% | -468.7% | -537.4% | -703.4% | -20,120.4% | -36.5% | -536.4% | 167.1% | -19,894.6% | -14,755.4% | |
| -713.9% | -550.9% | -515.5% | -653.1% | -16,185.2% | -35.4% | -521.0% | 187.7% | -18,726.8% | -14,546.9% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.